| 发明名称 |
TARGETING TELOMERASE FOR CELL THERAPY |
| 摘要 |
The present invention relates to stem cell technology. More particularly, the present invention relates to a method for engineering telomerase null pluripotent stem cells. These telomerase null stem cells remain pluripotent and have a limited life span and reduced tumor formation potential in vivo, which suggests they are useful for cell therapy. |
| 申请公布号 |
WO2016171625(A1) |
申请公布日期 |
2016.10.27 |
| 申请号 |
WO2016SG50190 |
申请日期 |
2016.04.22 |
| 申请人 |
NATIONAL UNIVERSITY OF SINGAPORE |
发明人 |
LI, Shang;LIU, Chang Ching;TAN, Patrick Boon Ooi;GOH, Eyleen Lay Keow;MA, Dongliang |
| 分类号 |
C12N5/0735;C12N5/074;C12N5/10 |
主分类号 |
C12N5/0735 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
